← Leaderboards
Magali Noval Rivas
Cedars-Sinai Medical Center
$6,076,549
Attributed
$7,677,867
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,677,867 · 3
By mechanism
R01$7,677,867 · 3
Top collaborators
- Moshe Arditi7 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Moshe Arditi$23,213,171
- Danica Jenine Schulte$508,080
- Ekaterina Koltsova$9,780,046
- Kenichi Shimada$2,668,750
Others in their field
Other Emerging Leaders on “Heart Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ashlin Bolton · Broad Institute, Inc.$22,970,454
- Patricia Shifflett · Westat, Inc.$16,650,520
- Bradley G Hammill · Duke University$15,773,864
- Bronwen Shaw · Medical College Of Wisconsin$15,731,163
- Ashok Kumar Krishnamurthy · Univ Of North Carolina Chapel Hill$14,171,772
Research focus
Heart DiseasesCellsTissuesCardiovascular SystemIntravenous ImmunoglobulinsLesionLactobacillus CaseiPathogenesisVasculitisAcuteChildChildhoodMucocutaneous Lymph Node SyndromeFeverImmuneCell WallBlood VesselsMouse ModelAbdominal AortaNovel TherapeuticsCoronaryEtiologyInterleukin-1Immunoglobulin G
Grant awards (17)
Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis$617,730
R01 · FY2025 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2024 · AI
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis$417,500
R01 · FY2024 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2023 · AI
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis$417,500
R01 · FY2023 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$191,748
R01 · FY2023 · AI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2022 · AI
Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis$437,500
R01 · FY2022 · HL · contact PI
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis$417,500
R01 · FY2022 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$99,079
R01 · FY2022 · AI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2021 · AI
Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis$437,500
R01 · FY2021 · HL · contact PI
Targeting the Sirt-1 pathway to modulate inflammation during murine Kawasaki Disease vasculitis$417,500
R01 · FY2021 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2020 · AI
Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis$437,500
R01 · FY2020 · HL · contact PI
Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis$437,500
R01 · FY2019 · HL · contact PI
Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis$437,500
R01 · FY2018 · HL · contact PI